• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis: A Step toward Personalized Therapy.

作者信息

Soenen Rani, Meulewaeter Evelyn, Grine Lynda, Van den Berghe Nathalie, Brouwers Els, Speeckaert Reinhart, Lanssens Sven, Temmerman Linda, Lambert Jo, Gils Ann

机构信息

Department of Dermatology, Ghent University Hospital, Ghent, Belgium.

Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.

出版信息

J Invest Dermatol. 2019 Oct;139(10):2232-2235.e1. doi: 10.1016/j.jid.2019.04.012. Epub 2019 May 5.

DOI:10.1016/j.jid.2019.04.012
PMID:31067484
Abstract
摘要

相似文献

1
Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis: A Step toward Personalized Therapy.确定银屑病中司库奇尤单抗的最低有效血清谷浓度：迈向个性化治疗的一步。
J Invest Dermatol. 2019 Oct;139(10):2232-2235.e1. doi: 10.1016/j.jid.2019.04.012. Epub 2019 May 5.
2
Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis: A Step Toward Personalized Treatment.制定阿达木单抗血清浓度治疗范围以管理银屑病：迈向个体化治疗的一步。
JAMA Dermatol. 2015 Jun;151(6):616-22. doi: 10.1001/jamadermatol.2014.5479.
3
Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study.依妥珠单抗治疗中重度慢性斑块状银屑病患者的长期疗效和安全性：一项双盲、随机撤药、安慰剂对照研究。
J Am Acad Dermatol. 2015 Aug;73(2):331-3.e1. doi: 10.1016/j.jaad.2015.03.040.
4
Treatment optimization with secukinumab 150 mg for moderate-to-severe psoriasis in clinical practice: a single-center open-label 52-week study.司库奇尤单抗150mg用于临床实践中中重度银屑病的治疗优化：一项单中心开放标签52周研究。
Int J Dermatol. 2018 May;57(5):615-617. doi: 10.1111/ijd.13953. Epub 2018 Feb 16.
5
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study.在中度至重度斑块型银屑病患者中，无论HLA-Cw6状态如何，司库奇尤单抗均显示出高效性：来自SUPREME研究扩展阶段的结果。
Br J Dermatol. 2019 Aug;181(2):413-414. doi: 10.1111/bjd.18013. Epub 2019 May 29.
6
Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: Extension of the 2PRECISE study.司库奇尤单抗治疗中重度掌跖脓疱型银屑病148周的疗效和安全性：2PRECISE研究的扩展
J Am Acad Dermatol. 2021 Feb;84(2):552-554. doi: 10.1016/j.jaad.2020.06.038. Epub 2020 Jun 18.
7
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial.司库奇尤单抗在清除中重度斑块状银屑病患者皮肤方面优于乌司奴单抗：CLEAR，一项随机对照试验。
J Am Acad Dermatol. 2015 Sep;73(3):400-9. doi: 10.1016/j.jaad.2015.05.013. Epub 2015 Jun 17.
8
Optimal concentration range of ustekinumab in patients with plaque-type psoriasis.斑块状银屑病患者中优特克单抗的最佳浓度范围。
J Am Acad Dermatol. 2019 Jun;80(6):1782-1784. doi: 10.1016/j.jaad.2018.12.021. Epub 2018 Dec 19.
9
Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks.司库奇尤单抗对银屑病患者内皮功能障碍及其他心血管疾病参数的影响：52 周研究结果
J Invest Dermatol. 2019 May;139(5):1054-1062. doi: 10.1016/j.jid.2018.10.042. Epub 2018 Nov 30.
10
Efficacy and safety of etanercept and adalimumab with and without a loading dose for psoriasis: A systematic review.依那西普和阿达木单抗在有或无负荷剂量情况下治疗银屑病的疗效与安全性：一项系统评价
J Am Acad Dermatol. 2015 Aug;73(2):329-31. doi: 10.1016/j.jaad.2015.04.012.

引用本文的文献

1
Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis.单克隆抗体的药代动力学和药效学特性对银屑病治疗的影响
Pharmaceutics. 2022 Mar 16;14(3):654. doi: 10.3390/pharmaceutics14030654.
2
Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis.皮肤科治疗药物监测：优化司库奇尤单抗治疗慢性斑块型银屑病的剂量方法。
Clin Exp Dermatol. 2022 Jul;47(7):1324-1336. doi: 10.1111/ced.15157. Epub 2022 Apr 25.
3
The Effects of Modified Intermittent Fasting in Psoriasis (MANGO): Protocol for a Two-Arm Pilot Randomized Controlled Open Cross-over Study.
改良间歇性禁食疗法对银屑病的影响（MANGO）：双臂试点随机对照开放交叉研究方案
JMIR Res Protoc. 2022 Feb 23;11(2):e26405. doi: 10.2196/26405.
4
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives.炎症性肠病生物制剂的治疗药物监测：未满足的需求和未来展望。
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):171-185. doi: 10.1016/S2468-1253(21)00223-5.
5
Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?在接受肿瘤坏死因子-α抑制剂治疗的化脓性汗腺炎患者中，治疗药物监测是否有作用？
Am J Clin Dermatol. 2021 Mar;22(2):139-147. doi: 10.1007/s40257-020-00579-z.
6
Achieving Mucosal Healing in Inflammatory Bowel Diseases: Which Drug Concentrations Need to Be Targeted?实现炎症性肠病的黏膜愈合：需要靶向哪些药物浓度？
Clin Pharmacol Ther. 2019 Nov;106(5):945-954. doi: 10.1002/cpt.1609. Epub 2019 Sep 20.